top of page
Blog
Search
Breaking News: NETTER-2 Trial Supports Lutathera® as 1st Line Treatment
The NETTER-2 phase 3 trial results show Lutathera® may be offered as first-line treatment for newly diagnosed grade 2 and 3 advanced...
NCF Team
Jan 26, 20241 min read
Â
Â
Â
bottom of page